- Reuters - UK Focus•6 months ago
A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to a misdemeanor related to its misbranding of the embolic device LC Bead, and will pay about $36 million to resolve its criminal and ...
- Reuters•7 months ago
British healthcare group BTG Plc said it agreed to settle an investigation into one of its U.S. units, Biocompatibles, with the U.S. Department of Justice for $36 million. BTG said its 2016-17 forecast for selling, general and administrative expenses did not include the effect of the settlement. BTG agreed to settle all allegations regarding the investigation, which focused on the period before it acquired the oncology products supplier Biocompatibles in 2011.
- Reuters - UK Focus•2 years ago
** Drugmaker Shire's model for growth, whereby successful products ramped up its valuation, giving it clout to make ever more expensive acquisitions, is taking seed in smaller rival BTG ** BTG's pioneering ...
BTGGF: Summary for BTG PLC - Yahoo Finance
BTG plc (BTGGF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
|Day's range||0.00 - 0.00|
Trade prices are not sourced from all markets
|PE ratio (TTM)||117.61|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|